600 patients66,869 observations120 daysLIVE

Patient P-01576

Synthetic patientNBL-101 · Day 108 · 75+ · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
71%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 31 NP-02 recommendedDietary Support Protocol NP-02
  3. Day 32 Patient acceptedStarted NP-02 in the companion
  4. Day 42 No meaningful changeDietary Support Protocol NP-02
  5. Day 45 Trajectory diverged from predictionObserved response fell below the model's expected path.
  6. Day 55 GI-04 recommendedGI Support Protocol GI-04
  7. Day 56 Patient acceptedStarted GI-04 in the companion
  8. Day 64 No meaningful changeGI Support Protocol GI-04

What changed?

Trajectory began diverging from predicted response on Day 45.

Primary contributors, last 14 days
  • GI instability-13
  • Inflammatory activity-13
  • Nutritional resilience+8
  • Toxicity-6
  • Treatment adherence+4

What helped?

  • Dietary Support Protocol NP-02Day 31
    Result: no meaningful change
  • GI Support Protocol GI-04Day 55
    Result: no meaningful change
LIFE OS recommendation
Monitoring Escalation ME-01
81%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 100% showed improvement
  • median effect visible after 3 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
52.9/100
stable · -0.9 vs previous 14 d
Toxicity
Blood
51.5/100
improving · -2.5 vs previous 14 d
Sleep quality
Wearable
1.7/100
improving · +2.8 vs previous 14 d
Energy level
Daily log
2.1/10
improving · +0.2 vs previous 14 d
Stress level
Daily log
6.6/10
stable · -0.3 vs previous 14 d
Steps
Wearable
3,423
worsening · -507 vs previous 14 d
Adherence
Companion
44.1 %
worsening · -2.2 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 33 from the failing basin, 55 from restoration.

Would help
  • ME-01 Monitoring Escalation
    100% improved among 77 similar · onset 3 d · confidence 69%
  • SC-12 Supportive Compound
    76% improved among 51 similar · onset 6 d · confidence 69%
  • CR-01 Clinician Review
    100% improved among 8 similar · onset 5 d · confidence 69%
Would not help
  • GI-04 GI Support Protocol
    already tried, no meaningful change
  • NP-02 Dietary Support Protocol
    already tried, no meaningful change
  • Keep fat low
    GI +2.1 next day on high-intake days · n 21
  • Keep fibre low
    GI +1.5 next day on high-intake days · n 19
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +2.1detractor · 86%
  • Insoluble fibre
    +1.5detractor · 56%
  • Histamine load
    +1.1no signal · 48%
  • Simple carbohydrates
    -1.1no signal · 38%
  • Spicy / capsaicin
    +1.1no signal · 45%
  • Alcohol
    +0.9no signal · 31%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 85
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 54
    • WearableHRV 22 ms, trending down
  • Autonomic recovery 65
    • WearableResting HR 73 bpm
    • Wearable3,423 steps/day
    • WearableShort sleep window
  • Mucosal barrier integrity 60
    • MicrobiomeAkkermansia low → thinner mucus layer
    • Daily logGI symptom score 53 and rising
    • WearableSleep 5.1 h, below personal baseline
  • Butyrate / short-chain fatty acid production 45
    • MicrobiomeF. prausnitzii depleted
    • Daily logFibre intake low in recent food logs
  • Drug metabolism and exposure 20
    • BloodToxicity index 52
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Intermediate metabolizer
    Expected exposure
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 3.1 · butyrate capacity 46/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
17 ms
Sleep
5.1 h
Steps
3,032
Resting HR
76 bpm
Daily log: GI score 53, nutritional resilience 43, adherence 44.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0181919%S1372
P-0160419%S0171
P-0138619%S1370
P-0135219%S2070
P-0175019%S1669
P-0169925%S04GI-04improved69
P-0150819%S1868
P-0150920%S1768
P-0187519%S1167
P-0181719%S1467
P-0187726%S01CR-01improved67
P-0162920%S1966